EPI-X4, a CXCR4 antagonist inhibits tumor growth in pancreatic cancer and lymphoma models.
Sagini MN, Zepp M, Eyol E, Ali DM, Gromova S, Dahlmann M, Behrens D, Groeschel C, Tischmeier L, Hoffmann J, Berger MR, Forssmann WG.
Sagini MN, et al. Among authors: ali dm.
Peptides. 2024 May;175:171111. doi: 10.1016/j.peptides.2023.171111. Epub 2023 Nov 28.
Peptides. 2024.
PMID: 38036098
Free article.